Redwire Corp
RDW NYSE Guided Missiles & Space Vehicles & Parts Financials FY2021βFY2025
What Redwire Corp does
No business description yet.
- Legal name
- Redwire Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001819810-26-000029
0001819810
Revenue and margins
Redwire Corp had $335M of revenue in fiscal 2025, up 10.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$191M in fiscal 2025, β56.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Redwire Corp returned β to shareholders in fiscal 2025. The diluted share count rose 80.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Redwire Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $20.5M | $28.3M | $30.3M | $33.7M | $94.5M |
| Debt incl. finance leases | $77.6M | $78.2M | $89.8M | $127M | $87.1M |
| Debt / equity | 0.7x | β | β | β | 0.1x |
| Interest coverage | β10.9x | β17.8x | β1.5x | β3.1x | β5.8x |
| Current ratio | 1.1x | 1.0x | 1.0x | 0.8x | 1.6x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 0.8x | 1.3x |
| Total assets | $262M | $258M | $271M | $293M | $1.4B |
| Total liabilities | $155M | $188M | $218M | $345M | $312M |
| Shareholders' equity | $107M | β$6.7M | β$43.5M | β$189M | $1.1B |
| Net debt (β = net cash) | $57.0M | $49.9M | $59.5M | $93.5M | β$7.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | 2 / 9 | 5 / 9 | 2 / 9 | 4 / 9 |
| Accruals ratio | β9.2% | β38.1% | β10.8% | β34.4% | β5.7% |
| Altman Z'' | β1.92 | β6.43 | β3.47 | β5.95 | 1.54 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $138M | $161M | $244M | $304M | $335M |
| Gross profit | $29.4M | $28.7M | $58.0M | $44.5M | $17.3M |
| Research and development | $4.5M | $4.9M | $5.0M | $6.1M | $19.8M |
| Operating income | β$70.2M | β$146M | β$15.5M | β$42.2M | β$230M |
| Interest expense | $6.5M | $8.2M | $10.7M | $13.5M | $39.8M |
| Pretax income | β$72.8M | β$139M | β$27.8M | β$116M | β$252M |
| Income tax | β$11.3M | β$8.0M | β$0.5M | β$2.0M | β$25.0M |
| Net income | β$61.5M | β$131M | β$27.3M | β$114M | β$227M |
| Net income to common | β$61.5M | β$132M | β$47.3M | β$155M | β$272M |
| Diluted EPS | β$1.36 | β$2.09 | β$0.73 | β$2.35 | β$2.28 |
| Diluted shares | 0.05B | 0.06B | 0.06B | 0.07B | 0.12B |
| Cash flow | |||||
| Cash from operations | β$37.4M | β$31.7M | $1.2M | β$17.3M | β$177M |
| Capital expenditure | $2.1M | $3.6M | $5.6M | $6.4M | $13.5M |
| Free cash flow | β$39.5M | β$35.3M | β$4.4M | β$23.7M | β$191M |
| Depreciation and amortization | $10.6M | $11.3M | $10.7M | $11.7M | $32.6M |
| Stock-based compensation | $27.1M | $10.8M | $8.7M | $11.3M | $59.0M |
| Acquisitions | $40.6M | $33.2M | $0.0M | $0.9M | $152M |
| Balance sheet | |||||
| Cash and short-term investments | $20.5M | $28.3M | $30.3M | $33.7M | $94.5M |
| Total debt | $77.6M | $77.3M | $88.2M | $126M | $85.2M |
| Finance lease liabilities | β | $0.9M | $1.6M | $1.5M | $1.9M |
| Current assets | $55.2M | $96.2M | $109M | $126M | $253M |
| Current liabilities | $51.2M | $94.7M | $112M | $149M | $156M |
| Inventory | $0.7M | $1.5M | $1.5M | $2.2M | $55.8M |
| Property and equipment, net | $19.4M | $12.8M | β | β | β |
| Goodwill | $96.3M | $64.6M | $65.8M | $71.2M | $779M |
| Intangible assets | $90.8M | $66.9M | $63.0M | $61.8M | $336M |
| Total assets | $262M | $258M | $271M | $293M | $1.4B |
| Total liabilities | $155M | $188M | $218M | $345M | $312M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $107M | β$6.7M | β$43.5M | β$189M | $1.1B |
| Margins | |||||
| Gross margin | 21.3% | 17.9% | 23.8% | 14.6% | 5.2% |
| Operating margin | β51.0% | β91.2% | β6.4% | β13.9% | β68.5% |
| EBITDA margin | β43.3% | β84.2% | β2.0% | β10.0% | β58.8% |
| Net margin | β44.7% | β81.4% | β11.2% | β37.6% | β67.6% |
| FCF margin | β28.7% | β22.0% | β1.8% | β7.8% | β56.9% |
| Returns | |||||
| Return on capital | β33.8% | β273.5% | β85.1% | β | β17.3% |
| Return on capital employed | β33.3% | β89.9% | β9.8% | β29.5% | β17.8% |
| Return on equity | β57.4% | β259.9% | β | β | β52.0% |
| Return on assets | β23.5% | β50.3% | β10.3% | β40.5% | β26.0% |
| Growth | |||||
| Revenue growth | β | 16.7% | 51.9% | 24.7% | 10.3% |
| Share count change | β | 40.5% | 2.1% | 2.3% | 80.7% |
| Financial health | |||||
| Debt / equity | 0.7x | β | β | β | 0.1x |
| Interest coverage | β10.9x | β17.8x | β1.5x | β3.1x | β5.8x |
| Current ratio | 1.1x | 1.0x | 1.0x | 0.8x | 1.6x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 0.8x | 1.3x |
| Capital allocation | |||||
| Capex / revenue | 1.5% | 2.3% | 2.3% | 2.1% | 4.0% |
| Stock comp / revenue | 19.7% | 6.7% | 3.6% | 3.7% | 17.6% |
| Quality scores | |||||
| Piotroski F-score | β | 2.0 | 5.0 | 2.0 | 4.0 |
| Altman Z'' | β1.9 | β6.4 | β3.5 | β5.9 | 1.5 |
| Accruals ratio | β9.2% | β38.1% | β10.8% | β34.4% | β5.7% |
Source: SEC EDGAR XBRL filings (CIK 0001819810). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.